Soya protein attenuates abnormalities of the renin-angiotensin system in adipose tissue from obese rats

María E Frigolet1, Nimbe Torres, Armando R Tovar

  • 1Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Colonia Seccion XVI, Mexico DF 14000, Mexico.

Insights

Dietary soy protein intake improves adipocyte function in obese rats by modulating the renin-angiotensin system (RAS) and angiogenesis-related genes, preventing negative metabolic changes.

Area of Science:

  • Metabolic disturbances and adipose tissue function in obesity.
  • Role of the renin-angiotensin system (RAS) in adipocyte signaling and angiogenesis.
  • Impact of dietary soy protein on metabolic health.

Background:

  • Obesity is linked to altered adipose tissue function and metabolic disturbances.
  • Adipocytes possess a local renin-angiotensin system (RAS) that influences angiogenesis via Akt signaling.
  • Dietary soy protein modifies gene expression in adipose tissue, potentially improving adipocyte function.

Purpose of the Study:

  • To investigate if dietary soy protein regulates RAS and angiogenesis-related gene expression in obese rats.
  • To determine the association between soy consumption, gene expression, and Akt phosphorylation in adipose tissue.
  • To evaluate soy's effect on adipocyte function and prevent obesity-related abnormalities.

Main Methods:

  • Obese rats were fed diets with soy protein or casein, at varying fat content (5% or 25%), for 160 days.
  • mRNA abundance of RAS and angiogenesis-related genes was analyzed in adipose tissue.
  • Akt phosphorylation and hormone release were measured in primary adipocyte cultures.

Main Results:

  • Soy consumption led to lower angiotensin release and enhanced insulin-stimulated Akt activation in adipocytes compared to casein.
  • Dietary soy modulated the expression of RAS and angiogenesis-related genes in high-fat diet-fed rats.
  • Soy intake prevented adipocyte hypertrophy and impaired angiogenesis, common in dysfunctional adipose tissue.

Conclusions:

  • Dietary soy protein preserves adipocyte functionality in obese rats.
  • Soy intake acts as a dietary strategy to prevent obesity-related metabolic abnormalities.
  • Modulation of RAS and angiogenesis pathways by soy contributes to improved adipose tissue health.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...